FDA Issues Clearance for ReWalk 7 Exoskeleton
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...
Mercado Libre Launches CFO Perspectives Series, Featuring CFO Martin de los Santos to Reflect on Q4’2024 Highlights
In the inaugural episode CFO Perspectives: Reflections on Q4 Results, now live on Spotify, Martin de los Santos and Richard Cathcart discuss key investor questions following Mercado Libre’s Q4 2024 ...
Executive Appointments Strengthen Nexxen’s Data, Streaming and Omnichannel Expertise
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Nexxen, a global, unified advertising technology platform with deep expertise in data and advanced TV, today announced the appointment of four new ...
ECD Auto Design Unveils the County Collection: A Celebration of British Heritage and Bespoke Craftsmanship
With its roots deeply embedded in British automotive culture, ECD Auto Design was founded on a passion for restoring and ...
NETSOL unveils Transcend AI Labs focused on building AI solutions for the asset retail and finance industry
The Transcend AI Labs launch features an interactive AI Assistant and Intelligent Document Processing (IDP) designed to boost efficiencies and enhance decision-making. These solutions are available as ...
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...
MCD, NSRGY, or UL: Which Consumer Goods Stock Offers the Best Volatility Safe Haven?
The current market selloff has many investors looking to shore up their portfolios with sturdy stocks that can weather the recessionary storm.
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Fourth Quarter 2024 Highlights On Dec. 20, 2024, Quoin announced the successful completion of a $6.8 million public offering, bolstering the company’s financial position to support ongoing clinical ...
Dorman releases more Dorman® OE FIX™ auto repair innovations and dozens of first-to-the-aftermarket solutions
COLMAR, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (NASDAQ:DORM) is announcing the release of 164 new automotive repair solutions this month for its Light Duty segment. Almost half ...
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...